Trade with Eva: Analytics in action >>

Friday, March 23, 2018

Progenics Pharma (PGNX) : FDA extends review of the New Drug Application for AZEDRA

Progenics Pharma announces that they have received notification from the FDA that the Agency will extend its review of the New Drug Application for AZEDRA (iobenguane I 131) by three months to July 30, 2018

** charts before announcement **

  





















** charts after announcement **

  


No comments:

Post a Comment